Govt panel allows phase-3 trial of Covovax as booster dose in adults
An expert panel of India's central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose in adults, official sources said on Sunday.
The Drugs Controller General Of India (DCGI) has already approved Covovax for restricted use in emergencies in adults on December 28.
It is yet to be included in the country's inoculation programme.
The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended permitting conducting a phase-3 clinical trial of the single-dose COVID-19 vaccine Sputnik Light as a booster dose.
In February, Director, Government and Regulatory Affairs at Serum Institute of India, Prakash Kumar Singh had sought from DCGI nod to conduct a pha...